EW Healthcare Partners held a final closing of EW Healthcare Partners Fund 2-A at $746.33 million, exceeding its $650 million target and surpassing capital raised by its predecessor, Essex Woodlands Fund IX, which closed in October 2016 at $543.10 million.
The fund will make growth equity investments in United States and European healthcare companies within the medical device, diagnostics and technology-enabled services and pharmaceutical sectors. Founded in 1985, EW Healthcare Partners has invested long-term in excess of 150 healthcare companies.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: